Potrero Medical, Inc.

Potrero Medical develops the Accuryn® Monitoring System, a next-generation smart catheter platform designed for early detection and prediction of acute kidney injury (AKI) in critical care settings. The system transforms a standard Foley catheter into an intelligent device that automates clinical data capture, visualizes kidney function trends, and provides real-time monitoring to enable earlier clinical interventions. The platform integrates with existing hospital workflows to reduce time clinicians spend managing data while increasing time spent with patients. Accuryn targets hospital ICU and acute care environments where AKI is prevalent, including post-sepsis monitoring and intra-abdominal compartment syndrome detection. The company focuses on predictive health capabilities that surface patterns not visible through traditional monitoring, addressing the significant clinical burden of AKI, which affects approximately 47.5% of sepsis patients and results in 300,000 annual US deaths. The system is positioned for use in adult critical care units, particularly in hospitals with high-acuity patient populations requiring intensive hemodynamic and renal function monitoring.